logo

For the Inventor, By the Inventor

Hamilton, OH, United States of America

Gerald W Dorn, Ii

This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: Mitochondria Emotion, Inc., Washington University, Leland Stanford Junior University. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald W Dorn, Ii. Retrieved from https://idiyas.com/inventor/gerald-w-dorn-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Hamilton, OH (US) (2013 - 2021)
  • St. Louis, MO (US) (2020 - 2023)

Company Filing History:

goldMedal3 out of 3 
 
Mitochondria Emotion, Inc.
 patents
silverMedal3 out of 1,381 
 
Washington University
 patents
bronzeMedal1 out of 5,512 
 
Leland Stanford Junior University
 patents
4. 1 out of 556 
 
University of Cincinnati
 patents
where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...
7 patents (USPTO):Explore Patents
1. 11760733 - Small molecule regulators of mitochondrial fusion and methods of use thereof (2023-09-19),
2. 11141390 - Mitofusin activators and methods of use thereof (2021-10-12),
3. 11083699 - Trans-4-hydroxycyclohexyl phenyl amide mitofusin activators and methods of use thereof (2021-08-10),
4. 11026904 - Mitofusin activators and methods of use thereof (2021-06-08),
5. 10844023 - Small molecule regulators of mitochondrial fusion and methods of use thereof (2020-11-24),
6. 10578610 - Peptide regulators of mitochondrial fusion and methods of use (2020-03-03),
7. 8530160 - G-protein coupled receptor kinase-5 polymorphism (2013-09-10),

Title: Gerald W Dorn, II: Innovator in Mitochondrial Research

Introduction

Gerald W Dorn, II is a prominent inventor based in Hamilton, OH (US), known for his significant contributions to mitochondrial research. With a total of seven patents to his name, Dorn has focused on developing small molecule regulators that enhance mitochondrial function. His work is crucial in addressing diseases associated with mitochondrial dysfunction.

Latest Patents

Dorn's latest patents include innovative compositions that comprise small molecule mitofusin agonists. These compositions are designed to treat diseases or disorders linked to mitochondrial dysfunction, particularly those associated with mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2). Additionally, he has developed methods of treatment, pharmaceutical formulations, and screening techniques for identifying compounds that regulate mitochondrial function. Another notable patent involves small molecule mitofusin activators, which are also aimed at treating mitochondrial-associated diseases and disorders.

Career Highlights

Throughout his career, Dorn has worked with esteemed institutions such as Washington University and Mitochondria Emotion, Inc. His research has significantly advanced the understanding of mitochondrial dynamics and their implications in various health conditions.

Collaborations

Dorn has collaborated with notable colleagues, including James Walter Janetka and Daria D Mochly-Rosen. These partnerships have further enriched his research and contributed to the development of innovative therapeutic strategies.

Conclusion

Gerald W Dorn, II stands out as a key figure in the field of mitochondrial research, with a focus on developing treatments for mitochondrial dysfunction. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…